Baxter Executive and Leadership Team

Glen Argyle, the General Manager, President & Representative Director at Baxter, directs significant operational and strategic functions within the company. This leadership position involves overseeing key business units and ensuring alignment with Baxter's overarching goals in the global healthcare market. Argyle's responsibilities encompass driving growth, managing P&L for designated areas, and representing the company in critical business dealings. The focus is on executing strategic initiatives that enhance Baxter's market presence and product offerings, including medical devices and pharmaceuticals. Glen Argyle's role is pivotal in navigating complex regulatory environments and fostering strong relationships with stakeholders across various regions. By leading with a clear vision, this executive ensures operational excellence and contributes to the company's sustained success in delivering essential healthcare solutions. Glen Argyle's strategic direction is fundamental to Baxter's continued impact on patient care.

Jill Schaaf, the CVP, President Renal at Baxter, leads the company's comprehensive renal care business segment. This executive is responsible for driving innovation, market expansion, and operational excellence within the renal therapies division, which includes dialysis products and services. Schaaf's leadership focuses on enhancing patient access to life-sustaining treatments and advancing the standard of care for individuals with kidney disease. By overseeing product development, manufacturing, and commercial strategies, Jill Schaaf ensures Baxter's renal portfolio meets the evolving needs of patients and healthcare providers globally. This critical role involves close coordination with research and development teams to bring new technologies to market and optimize existing offerings. Jill Schaaf's strategic oversight is essential for maintaining Baxter's leadership in the renal care sector and improving the quality of life for millions worldwide. The President Renal's dedication shapes the future of kidney disease management.

Cecilia Soriano, the Group President, Infusion Therapies Technologies & Pharmaceuticals at Baxter, spearheads the strategic direction and operational performance of critical business units. This executive oversees the development, manufacturing, and commercialization of infusion systems, advanced drug delivery technologies, and a broad range of pharmaceutical products. Soriano's leadership is instrumental in driving innovation across these segments, ensuring Baxter delivers high-quality solutions that improve patient outcomes and enhance healthcare efficiency. By managing global operations and market strategies, Cecilia Soriano supports Baxter's commitment to providing essential medical devices and therapies to hospitals and clinics worldwide. This role demands a deep understanding of complex healthcare markets and regulatory landscapes. Cecilia Soriano's focus on technological advancement and product excellence solidifies Baxter's position as a leader in infusion therapies and pharmaceuticals. The Group President's vision guides the evolution of these vital healthcare offerings.

Julie Foster, the President, Front Line Care at Baxter, directs the strategic vision and operational execution for a key segment focused on patient care solutions. This leadership position involves overseeing the development, marketing, and distribution of products designed for direct patient use and clinical settings. Foster's responsibilities include driving innovation in areas such as medication delivery, respiratory care, and patient monitoring, ensuring these offerings meet the highest standards of quality and efficacy. By focusing on the needs of healthcare providers and patients at the point of care, Julie Foster enhances Baxter's ability to deliver comprehensive solutions. This executive's strategic insights are crucial for expanding market reach and strengthening Baxter's reputation for reliability and advanced medical technology. Julie Foster's leadership ensures the Front Line Care division consistently contributes to improved patient safety and clinical outcomes globally. The President's commitment advances essential healthcare services.

Joy Amundson, the CVP and President Baxter BioScience at Baxter, leads the company's strategic initiatives within the biosciences sector. This executive is responsible for driving growth and innovation in areas such as biopharmaceuticals, vaccines, and advanced therapeutic solutions. Amundson's leadership focuses on expanding Baxter's capabilities in biological product development and manufacturing, ensuring high-quality standards and regulatory compliance. By overseeing commercial operations and market strategies, Joy Amundson strengthens Baxter's presence in the global bioscience landscape. This role involves fostering key partnerships and collaborations to accelerate the delivery of life-saving and life-enhancing biological products. The President Baxter BioScience's vision is critical for advancing scientific discovery and meeting unmet medical needs worldwide. Joy Amundson's direction propels Baxter's contributions to global health through cutting-edge bioscience.

Stacey Eisen, the ​Senior Vice President, Chief Communications Officer and Corporate Marketing, and President, Baxter Foundation at Baxter, directs the company's comprehensive communication strategies and corporate branding efforts. This executive oversees all internal and external communications, ensuring a consistent and compelling message across global platforms. Eisen's responsibilities include shaping Baxter's corporate identity, managing public relations, and leading marketing initiatives that highlight the company's commitment to healthcare innovation. As President of the Baxter Foundation, Stacey Eisen also guides philanthropic endeavors, reinforcing the company's dedication to improving global health outcomes. By integrating communications, marketing, and corporate social responsibility, this leader enhances Baxter's reputation and stakeholder engagement. Stacey Eisen's strategic oversight ensures that Baxter's mission and values resonate with employees, customers, and the wider community. The Chief Communications Officer's influence amplifies Baxter's impact.

Olga Selina, the Vice President, Information Technology Artificial Intelligence (Ai) & Data, Medical Products & Therapies Information (Segment Technology Leader & Chief Information Officer at Baxter, directs the strategic integration of artificial intelligence and data analytics across the Medical Products & Therapies segments. This leadership role involves architecting advanced data governance frameworks and driving the adoption of AI-driven solutions to enhance product development and operational efficiency. Overseeing the technology roadmap for these critical business units, Olga Selina ensures that information systems support Baxter's mission to deliver innovative medical devices and therapies. The focus remains on leveraging data to improve patient outcomes and streamline healthcare delivery globally. This executive's purview includes managing complex IT infrastructures and fostering a culture of data-driven decision-making throughout the organization. Olga Selina's efforts are central to advancing Baxter's position in the competitive healthcare technology landscape.

Rusty Patel, the Senior Vice President & Chief Information Officer at Baxter, architects the company's global information technology strategy and infrastructure. This executive oversees all aspects of IT operations, ensuring robust cybersecurity measures and driving digital transformation initiatives across the enterprise. Patel's leadership focuses on enhancing operational agility and supporting Baxter's diverse portfolio of medical devices, pharmaceuticals, and hospital care products. By optimizing IT systems and implementing innovative technological solutions, Rusty Patel directly supports the development and delivery of critical healthcare offerings worldwide. This role involves close collaboration with other senior leaders to align technology investments with business objectives, ensuring seamless integration of systems that facilitate Baxter's global reach. The Chief Information Officer's strategic vision is crucial for maintaining competitive advantage and driving efficiency in a rapidly evolving healthcare market. Rusty Patel's guidance ensures technology empowers Baxter's mission to improve patient care.

Tobi Karchmer, the Senior VP & Chief Medical & Scientific Officer at Baxter, provides critical medical and scientific leadership across the organization. This executive guides research and development initiatives, ensuring that Baxter's product pipeline aligns with the latest scientific advancements and clinical needs. Karchmer's role involves overseeing clinical trials, evaluating new technologies, and ensuring the safety and efficacy of Baxter's medical devices, pharmaceuticals, and therapies. By fostering collaboration between scientific teams and commercial operations, Tobi Karchmer drives innovation that addresses complex healthcare challenges. This leadership position is essential for maintaining Baxter's commitment to evidence-based medicine and scientific integrity. The Chief Medical & Scientific Officer's expertise informs strategic decisions, product development, and regulatory submissions, ensuring Baxter remains at the forefront of medical innovation. Tobi Karchmer's influence shapes the scientific direction of the company.

Sylvia Quinones, the Nefrologa at Baxter, contributes specialized medical expertise to the company's renal care initiatives. This role focuses on providing clinical insights and guidance related to kidney diseases and their treatment. Quinones's contributions are vital for ensuring Baxter's renal products and services meet the highest standards of patient care and clinical effectiveness. By leveraging deep knowledge of nephrology, Sylvia Quinones supports the development of innovative solutions for patients undergoing dialysis and managing chronic kidney conditions. This executive's input helps align Baxter's offerings with the evolving needs of the medical community and patient populations worldwide. The Nefrologa's perspective is crucial for advancing Baxter's mission to improve the lives of individuals affected by renal disorders. Sylvia Quinones's dedication enhances the clinical relevance of Baxter's renal therapies.